Literature DB >> 22156594

IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection.

Ester Roffê1, Antonio Gigliotti Rothfuchs, Helton C Santiago, Ana Paula M P Marino, Flavia L Ribeiro-Gomes, Michael Eckhaus, Lis R V Antonelli, Philip M Murphy.   

Abstract

Chagas' disease is a zoonosis prevalent in Latin America that is caused by the protozoan Trypanosoma cruzi. The immunopathogenesis of cardiomyopathy, the main clinical problem in Chagas' disease, has been extensively studied but is still poorly understood. In this study, we systematically compared clinical, microbiologic, pathologic, immunologic, and molecular parameters in two mouse models with opposite susceptibility to acute myocarditis caused by the myotropic Colombiana strain of T. cruzi: C3H/HeSnJ (100% mortality, uncontrolled parasitism) and C57BL/6J (<10% mortality, controlled parasitism). T. cruzi induced differential polarization of immunoregulatory cytokine mRNA expression in the hearts of C57BL/6J versus C3H/HeSnJ mice; however, most differences were small. The difference in IL-10 expression was exceptional (C57BL/6J 8.7-fold greater than C3H/HeSnJ). Consistent with this, hearts from infected C57BL/6J mice, but not C3H/HeSnJ mice, had a high frequency of total IL-10-producing CD8(+) T cells and both CD4(+) and CD8(+) subsets of IFN-γ(+)IL-10(+) double-producing T cells. Furthermore, T. cruzi infection of IL-10(-/-) C57BL/6J mice phenocopied fatal infection in wild-type C3H/HeSnJ mice with complete loss of parasite control. Adoptive transfer experiments indicated that T cells were a source of protective IL-10. Thus, in this system, IL-10 production by T cells promotes T. cruzi control and protection from fatal acute myocarditis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156594      PMCID: PMC3253255          DOI: 10.4049/jimmunol.1003845

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi.

Authors:  Braulia C Caetano; Bianca B Carmo; Mariane B Melo; Anna Cerny; Sara L dos Santos; Daniella C Bartholomeu; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

3.  Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR.

Authors:  Kara L Cummings; Rick L Tarleton
Journal:  Mol Biochem Parasitol       Date:  2003-06       Impact factor: 1.759

4.  Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice.

Authors:  C Hölscher; M Mohrs; W J Dai; G Köhler; B Ryffel; G A Schaub; H Mossmann; F Brombacher
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite.

Authors:  M A Campos; I C Almeida; O Takeuchi; S Akira; E P Valente; D O Procópio; L R Travassos; J A Smith; D T Golenbock; R T Gazzinelli
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

6.  Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi.

Authors:  Ana-Carolina Oliveira; Jaqueline R Peixoto; Luciana B de Arruda; Marco A Campos; Ricardo T Gazzinelli; Douglas T Golenbock; Shizuo Akira; José O Previato; Lúcia Mendonça-Previato; Alberto Nobrega; Maria Bellio
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

7.  Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules.

Authors:  P V dos Santos; E Roffê; H C Santiago; R A Torres; A P Marino; C N Paiva; A A Silva; R T Gazzinelli; J Lannes-Vieira
Journal:  Microbes Infect       Date:  2001-10       Impact factor: 2.700

8.  Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response.

Authors:  J A S Gomes; L M G Bahia-Oliveira; M O C Rocha; O A Martins-Filho; G Gazzinelli; R Correa-Oliveira
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

9.  Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival.

Authors:  R Wrightsman; S Krassner; J Watson
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

10.  Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi.

Authors:  Vladimir Michailowsky; Mara R N Celes; Ana P Marino; Andréa A Silva; Leda Q Vieira; Marcos A Rossi; Ricardo T Gazzinelli; Joseli Lannes-Vieira; João S Silva
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  47 in total

1.  Low-Level Parasite Persistence Drives Vasculitis and Myositis in Skeletal Muscle of Mice Chronically Infected with Trypanosoma cruzi.

Authors:  Joseph D Weaver; Victoria J Hoffman; Ester Roffe; Philip M Murphy
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

Review 2.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

3.  T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.

Authors:  Marcela Helena Gonçalves Pereira; Maria Marta Figueiredo; Camila Pereira Queiroz; Télcia Vasconcelos Barros Magalhães; Adriana Mafra; Lilian Martins Oliveira Diniz; Último Libânio da Costa; Kenneth J Gollob; Lis Ribeiro do Valle Antonelli; Helton da Costa Santiago
Journal:  Immunology       Date:  2020-04-06       Impact factor: 7.397

Review 4.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It.

Authors:  Eva V Acosta Rodríguez; Cintia L Araujo Furlan; Facundo Fiocca Vernengo; Carolina L Montes; Adriana Gruppi
Journal:  Trends Parasitol       Date:  2019-10-10

5.  Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice.

Authors:  Ester Roffê; Ana Paula M P Marino; Joseph Weaver; Wuzhou Wan; Fernanda F de Araújo; Victoria Hoffman; Helton C Santiago; Philip M Murphy
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 6.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

7.  Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi.

Authors:  J Nihei; F Cardillo; W L C Dos Santos; L Pontes-de-Carvalho; J Mengel
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21

8.  Andrographolide attenuates viral myocarditis through interactions with the IL-10/STAT3 and P13K/AKT/NF-κβ signaling pathways.

Authors:  Yaxin Zhao; Meng Wang; Yang Li; Wanting Dong
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

Review 9.  Management of inflammation in cardiovascular diseases.

Authors:  Sumanta Kumar Goswami; Prabhat Ranjan; Roshan Kumar Dutta; Suresh Kumar Verma
Journal:  Pharmacol Res       Date:  2021-09-23       Impact factor: 7.658

10.  Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.

Authors:  Rafael Polidoro Alves Barbosa; Bruno Galvão Filho; Luara Isabela Dos Santos; Policarpo Ademar Sales Junior; Pedro Elias Marques; Rafaela Vaz Sousa Pereira; Denise Carmona Cara; Oscar Bruña-Romero; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Alexandre Vieira Machado
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.